CTL-HBV

N/A

Report date: 2025/03/19 16:06:33

Base Information

Drug NameCTL-HBV

Drug Alias NameCTL-HBV

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionHepatitis B virus inhibitors

TargetsHepatitis B virus

Therapy Area/IndicationsHepatitis B, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPharos Vaccine Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHepatitis B, Chronic

Inactive IndicationsN/A

ATC CodeN/A